Note: If you have any questions regarding your
... staining your teeth and tongue; however, good brushing before using the rinse can help minimize this. Upon completion of therapy, Dr. Massoth’s staff will remove any residual staining resultant of this rinse. Do not rinse with water after using chlorhexidine. IBUPROFEN (Advil) Ibuprofen is a nonster ...
... staining your teeth and tongue; however, good brushing before using the rinse can help minimize this. Upon completion of therapy, Dr. Massoth’s staff will remove any residual staining resultant of this rinse. Do not rinse with water after using chlorhexidine. IBUPROFEN (Advil) Ibuprofen is a nonster ...
Veltassa
... Indicated for the treatment of hyperkalemia. Not to be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action. Hypersensitivity to patiromer sorbitex calcium or xanthan gum Patiromer binds to many orally administered medications, which could decre ...
... Indicated for the treatment of hyperkalemia. Not to be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action. Hypersensitivity to patiromer sorbitex calcium or xanthan gum Patiromer binds to many orally administered medications, which could decre ...
Low Residue Diet - Cambridge Colorectal
... out in the stool. Plant fibre forms most of the residue in our diet. Fibre comes from the undigested part of fruits, vegetables and grains. A low residue diet reduces the amount of fibre passing through the colon and so lessens stool bulk. This type of diet may also be called a low fibre or restrict ...
... out in the stool. Plant fibre forms most of the residue in our diet. Fibre comes from the undigested part of fruits, vegetables and grains. A low residue diet reduces the amount of fibre passing through the colon and so lessens stool bulk. This type of diet may also be called a low fibre or restrict ...
daily fiber blend - 500 g
... (in noodles, tofu, etc.) for over 1000 years. Recent studies have shown that its health benefits may include: cholesterol reduction, blood sugar regulation, constipation relief, and appetite suppression. The term `heirloom` has been applied to the ancient grains (quinoa, amaranth, spelt, and Kamut) ...
... (in noodles, tofu, etc.) for over 1000 years. Recent studies have shown that its health benefits may include: cholesterol reduction, blood sugar regulation, constipation relief, and appetite suppression. The term `heirloom` has been applied to the ancient grains (quinoa, amaranth, spelt, and Kamut) ...
antibiotics - Crohn`s and Colitis Foundation of America
... Medical treatment for Crohn’s disease and ulcerative colitis has two main goals: achieving remission (control or resolution of inflammation leading to symptom resolution) and then maintaining remission. These goals should be achieved with as few side effects and as little risk as possible. Antibioti ...
... Medical treatment for Crohn’s disease and ulcerative colitis has two main goals: achieving remission (control or resolution of inflammation leading to symptom resolution) and then maintaining remission. These goals should be achieved with as few side effects and as little risk as possible. Antibioti ...
liver diseases
... deposited in the skin and cause itching. 2. co-amoxiclav is a likely cause here, although a complete history is required to exclude other drugs or causes of illness or pre-existing liver disease. 3. -Symptomatic treatment of the itch with antihistamines is appropriate. - Topical treatment with menth ...
... deposited in the skin and cause itching. 2. co-amoxiclav is a likely cause here, although a complete history is required to exclude other drugs or causes of illness or pre-existing liver disease. 3. -Symptomatic treatment of the itch with antihistamines is appropriate. - Topical treatment with menth ...
IBS SIBO
... interpret and although breath testing appears to be more commonly abnormal in IBS patients based on studies this test is imperfect for definitively identifying SIBO. Evidence of the involvement of bacteria in IBS provides a rationale for the potential therapeutic benefit of antibiotic treatment. Sev ...
... interpret and although breath testing appears to be more commonly abnormal in IBS patients based on studies this test is imperfect for definitively identifying SIBO. Evidence of the involvement of bacteria in IBS provides a rationale for the potential therapeutic benefit of antibiotic treatment. Sev ...
irritable_bowel_syndrome
... • Response to treatment varies and affected dogs may have long-term, intermittent clinical signs • Eliminate any stressful factors in the dog's environment, if possible ...
... • Response to treatment varies and affected dogs may have long-term, intermittent clinical signs • Eliminate any stressful factors in the dog's environment, if possible ...
polyethylene glycol (po-lee-eth-e-leenglye-kole)
... Contraindicated in: GI obstruction; Gastric retention; Toxic colitis; Megacolon; Bowel perforation. ...
... Contraindicated in: GI obstruction; Gastric retention; Toxic colitis; Megacolon; Bowel perforation. ...
Document
... The use of oil-based laxatives should be avoided because they reduce the tensile strength and "burst" volume of latex products ...
... The use of oil-based laxatives should be avoided because they reduce the tensile strength and "burst" volume of latex products ...
GI ProDrugs Medicines for Inflammatory Bowel Disease Introduction:
... types. GI ProDrugs are a group of proprietary treatments for IBD based on targeting technology developed at the School of Pharmacy and the School of Medicine at TCD. Chemical drug targeting involves the deliberate modification of a drug structure causing it to accumulate at the target tissue, enhanc ...
... types. GI ProDrugs are a group of proprietary treatments for IBD based on targeting technology developed at the School of Pharmacy and the School of Medicine at TCD. Chemical drug targeting involves the deliberate modification of a drug structure causing it to accumulate at the target tissue, enhanc ...
Rectal drug administration
... volume is low the rectum is generally empty absorption adjuvants have a more pronounced effect than in the upper gastrointestinal tract degradative enzymes in the rectal lumen are at relatively low concentrations therapy can easily be discontinued first-pass elimination of drug by the liver is partl ...
... volume is low the rectum is generally empty absorption adjuvants have a more pronounced effect than in the upper gastrointestinal tract degradative enzymes in the rectal lumen are at relatively low concentrations therapy can easily be discontinued first-pass elimination of drug by the liver is partl ...
Anti-obesity medication
Anti-obesity medication or weight loss drugs are all pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.In the United States only one anti-obesity medication orlistat (Xenical) is currently approved by the FDA for long term use. It reduces intestinal fat absorption by inhibiting pancreatic lipase. Rimonabant (Acomplia), a second drug, works via a specific blockade of the endocannabinoid system. It has been developed from the knowledge that cannabis smokers often experience hunger, which is often referred to as ""the munchies"". It had been approved in Europe for the treatment of obesity but has not received approval in the United States or Canada due to safety concerns. The European Medicines Agency in October 2008 recommended the suspension of the sale of rimonabant as the risks seem to be greater than the benefits. Sibutramine (Meridia), which acts in the brain to inhibit deactivation of the neurotransmitters, thereby decreasing appetite was withdrawn from the United States and Canadian markets in October 2010 due to cardiovascular concerns.Because of potential side effects, it is recommended that anti-obesity drugs only be prescribed for obesity where it is hoped that the benefits of the treatment outweigh its risks.